Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2022-08-08 Purchase | 2022-08-10 6:13 pm | Poseida Therapeutics Inc. | PSTX | Ostertag Eric Executive Chairman 10% Owner | 142,857 | $3.5 | $500,000 | 9,398,519 (Indirect Direct) | View |
2022-08-03 Sale | 2022-08-05 4:09 pm | Poseida Therapeutics Inc. | PSTX | Ostertag Eric Executive Chairman 10% Owner | 160,696 | $3.689 | $592,808 | 9,255,662 (Indirect Direct) | View |
2021-11-08 Sale | 2021-11-10 6:06 pm | Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner | 18,924 | $7.09 | $134,171 | 5,806,212 (Indirect Direct) | View |
2021-10-01 Sale | 2021-10-05 6:16 pm | Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner | 20,029 | $7.02 | $140,604 | 5,794,256 (Indirect Direct) | View |
2021-09-20 Sale | 2021-09-22 5:51 pm | Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner | 20,000 | $8.001 | $160,020 | 9,483,661 (Indirect Direct) | View |
2021-09-14 Sale | 2021-09-15 6:58 pm | Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner | 20,000 | $8.1356 | $162,712 | 10,263,181 (Indirect Direct) | View |
2021-09-01 Sale | 2021-09-03 4:54 pm | Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner | 112,411 | $8.3946 | $943,646 | 5,822,554 (Indirect Direct) | View |
2021-08-02 Sale | 2021-08-04 4:57 pm | Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner | 33,673 | $8.0471 | $270,970 | 5,765,167 (Indirect Direct) | View |
2021-07-01 Sale | 2021-07-06 5:35 pm | Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner | 48,105 | $9.275 | $446,174 | 5,781,272 (Indirect Direct) | View |
2021-06-01 Sale | 2021-06-03 7:21 pm | Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner | 81,916 | $8.4758 | $694,302 | 5,804,278 (Indirect Direct) | View |
2021-05-03 Sale | 2021-05-05 7:29 pm | Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner | 54,312 | $8.6323 | $468,839 | 5,843,455 (Indirect Direct) | View |
2021-04-01 Sale | 2021-04-05 7:50 pm | Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner | 115,000 | $9.6087 | $1,104,998 | 5,866,944 (Indirect Direct) | View |
2021-03-01 Sale | 2021-03-03 7:38 pm | Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner | 115,000 | $11.6 | $1,334,461 | 5,924,431 (Indirect Direct) | View |
2021-02-16 Sale | 2021-02-17 5:28 pm | Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner | 133,149 | $10 | $1,332,036 | 9,840,253 (Indirect Direct) | View |
2021-02-10 Sale | 2021-02-12 5:03 pm | Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner | 12,389 | $10 | $123,890 | 9,973,402 (Indirect Direct) | View |
2021-01-21 Sale | 2021-01-25 7:42 pm | Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner | 4,462 | $10 | $44,620 | 9,918,257 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-02-01 Tax Withholding | 2023-02-03 4:19 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Ostertag Eric Director | 11,776 | $7 | 6,028,560 (Direct) | View |
Ownership | 2023-01-17 9:18 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Ostertag Eric Director | 0 | $0 | 6,040,336 (Direct) | View |
2022-02-01 Option Award | 2022-02-01 9:48 pm | N/A 2032-01-31 | Poseida Therapeutics Inc. | PSTX | Ostertag Eric Executive Chairman 10% Owner | 219,000 | $0 | 9,542,858 (Direct) | View |
2021-12-30 Gift | 2022-02-01 9:48 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Ostertag Eric Executive Chairman 10% Owner | 142,857 | $0 | 9,542,858 (Direct) | View |
2021-11-19 Exercise | 2021-11-22 7:50 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner | 1,000 | $9.15 | 10,206,710 (Direct) | View |
2021-11-19 Exercise | 2021-11-22 7:50 pm | N/A 2031-02-03 | Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner | 1,000 | $0 | 10,206,710 (Direct) | View |
2021-10-11 Exercise | 2021-10-13 6:59 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner | 18,525 | $9.15 | 10,225,634 (Direct) | View |
2021-10-11 Exercise | 2021-10-13 6:59 pm | N/A 2031-02-03 | Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner | 18,525 | $0 | 10,225,634 (Direct) | View |
2021-09-13 Exercise | 2021-09-15 6:58 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner | 18,524 | $9.15 | 10,263,181 (Direct) | View |
2021-09-13 Exercise | 2021-09-15 6:58 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner | 2,757 | $1.173 | 10,263,181 (Direct) | View |
2021-09-13 Exercise | 2021-09-15 6:58 pm | N/A 2026-02-28 | Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner | 21,281 | $0 | 10,263,181 (Direct) | View |
2021-08-06 Exercise | 2021-08-10 6:56 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner | 111,149 | $9.15 | 10,392,835 (Direct) | View |
2021-08-06 Exercise | 2021-08-10 6:56 pm | N/A 2031-02-03 | Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner | 111,149 | $0 | 10,392,835 (Direct) | View |
Ownership(A) | 2021-05-05 7:27 pm | N/A 2021-02-28 | Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner | 0 | $0 | 99,610 (Direct) | View |
2021-02-23 Exercise | 2021-02-25 7:01 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner | 111,395 | $1.173 | 9,954,405 (Direct) | View |
2021-02-23 Exercise | 2021-02-25 7:01 pm | N/A 2026-02-28 | Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner | 111,395 | $0 | 9,954,405 (Direct) | View |
2021-02-10 Exercise | 2021-02-12 5:03 pm | N/A 2026-02-28 | Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner | 67,534 | $0 | 9,973,402 (Direct) | View |
2021-02-10 Exercise | 2021-02-12 5:03 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner | 67,534 | $1.29 | 9,973,402 (Direct) | View |
2021-02-04 Option Award | 2021-02-05 4:51 pm | N/A 2031-02-03 | Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner | 889,193 | $0 | 889,193 (Direct) | View |
2020-07-14 Conversion | 2020-07-15 5:00 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner | 1,362,898 | $0 | 9,293,525 (Indirect) | View |
Ownership | 2020-07-09 6:00 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Ostertag Eric Chief Executive Officer 10% Owner | 0 | $0 | 10,344,981 (Direct) | View |